Replacing Drugs With Supplements Is Not Functional Medicine. And Here's the Pattern That Keeps Creating It.

Here is how it happens. A practitioner learns the optimal ranges. They see a patient with fifteen sub-optimal markers. They match each marker to a targeted supplement. They call it personalised functional medicine. It is, in fact, pharmaceutical medicine with a different product catalogue and a better story.

I want to start with what this pattern is not. It is not stupidity. It is not laziness. It is not cynicism. It is the entirely logical output of training that teaches practitioners to identify problems with precision and then provides them with intervention options for each problem — without providing a clinical framework that asks whether the problem being identified is the problem worth addressing.

The supplement-for-every-finding pattern is the natural endpoint of range training without clinical philosophy. And I think it's worth being direct about that, because the same training market that created the pattern is also selling the solution — usually in the form of more specialised range training, more targeted supplement protocols, and more precise symptom-to-supplement matching.

The loop is complete. The problem generates the revenue that funds more of the problem.

What Makes Something Functional Medicine

The word "functional" in functional medicine has a specific meaning. It refers to the functioning of upstream systems as the primary clinical lens — not the downstream symptoms those systems produce. Functional medicine is not defined by the tools it uses, the ranges it references, or the products it recommends. It is defined by the question it asks.

That question is: what is upstream of this patient's presentation, and what does the body need in order to resolve the source rather than manage the output?

If you're asking that question — genuinely, with a clinical framework that tells you how to find the upstream cause and what to do once you find it — you're practising functional medicine. If you're asking a different question — "which supplement addresses this suboptimal finding?" — you are practising symptom medicine. The supplement is a more natural product than a pharmaceutical. The framework is the same.

The intervention is not what makes something functional medicine. The question that precedes the intervention is.

The Range Training Connection

I want to be specific about how the range training market contributes to this pattern, because I think it's a connection that's rarely made explicitly.

Range training teaches practitioners to identify sub-optimal findings. That's its purpose, and it does it well. The implicit clinical logic that follows from identifying a sub-optimal finding is: this needs to be addressed. Address it. The training typically provides protocols — supplement combinations that target the identified finding.

What the training does not typically ask is: what is producing this sub-optimal finding, and is addressing this finding directly the right starting point? Is this finding downstream of something else? Is there an upstream driver that, if addressed, would allow this marker to self-correct without direct intervention?

Those questions require a clinical framework, not range knowledge. And the training market — which has a financial interest in the identification-and-protocol loop — has not been incentivised to provide them.

Why the Supplement Loop Produces Poor Outcomes

The clinical reason the supplement-for-finding pattern produces variable and often temporary results is the same reason that pharmaceutical symptom management produces variable and often temporary results: you are working against the upstream pressure rather than removing it.

A patient with chronically low ferritin is likely not low on iron. They are likely dealing with an inflammatory load — often pathogenic in origin — that is actively suppressing iron storage. Supplement iron into that patient for six months. The ferritin may improve. When the supplementation stops, the inflammatory load continues, the suppression resumes, and the ferritin drops again.

You have not addressed the root cause. You have managed the output of the root cause, at cost to the patient in supplement spend and to your practice in the retention problem that results when patients plateau and drift.

The same logic applies to almost every category of sub-optimal finding in a chronically unwell patient. The downstream is a reporting mechanism. The upstream is the story. Supplement the downstream without reading the story and you're perpetually catching water coming out of a tap rather than turning the tap off.

What Distinguishes Root-Cause Practice in Reality

I want to offer something concrete here rather than just critique, because the goal is not to dismiss supplement use — it's to correctly position it in the clinical sequence. Supplements have a genuine and significant role in functional medicine. They become genuinely powerful when they are used in sequence — when the upstream burden has been cleared, drainage has been opened, and the body is in a state where targeted nutritional support can produce lasting change rather than temporary improvement. The supplement is not the problem. Using it as a first response to a downstream finding, without clearing the upstream, is the problem.

The clinical sequencing principle is: drainage first, clearance in biological order (larger organisms before smaller, external before internal), biofilm disruption where indicated, and targeted optimisation last. When you follow that sequence, the supplement protocols that follow are genuinely effective — because the conditions for them to work have been established.

That sequencing framework is what FMFT's clinical architecture is built around — not the ranges, not the protocols, but the philosophical foundation that makes both the ranges and the protocols clinically meaningful. If you want to understand what that looks like in a practice context, you can read more at functionalmedicinefasttrack.com